Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2002
06/13/2002US20020071808 Method for imaging malignant tumors using carbon 13 with MRI
06/13/2002US20020071807 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
06/13/2002CA2436601A1 Perturbed membrane-binding compounds
06/12/2002EP1212103A1 4-fluoroalkyl-3-halophenyl nortropanes
06/12/2002EP0888354B1 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same
06/11/2002US6403771 Loading onto binding medium relatively long lived radioisotope, decay sequence yielding daughter isotopes that emit predominantly alpha-and/or beta-particles, eluting alpha-particle emitting isotope, coupling to targeting moiety
06/11/2002US6403096 Dimer, linked by a disulfide bridge; improves the uptake of therapeutic and diagnostic agents at a tumor site
06/11/2002US6403091 Produced by the hybridoma having atcc accession no. hb 10916.
06/11/2002US6403054 Ternary ligand complexes useful as radiopharmaceuticals
06/06/2002WO2002044217A2 Humanised antibodies and uses thereof
06/06/2002WO2002044175A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
06/06/2002WO2002044144A2 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
06/06/2002WO2002043776A2 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer
06/06/2002WO2002043570A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
06/06/2002WO2001066155A3 Actinium-225 complexes and conjugates for radioimmunotherapy
06/06/2002US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer
06/06/2002US20020068328 Liposomal pharmaceutical conjugate for use inthe treatment and diagnosis of tumors; antitumor agents; anticarcinogeneic agents
06/06/2002US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
06/06/2002US20020068037 Cascade polymer bound complexing compounds, their complexes and conjugates, process for their production, and pharmaceutical agents containing them
06/06/2002DE10040381C1 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with sugar residues, processes for their preparation and their use
06/06/2002CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies
06/06/2002CA2429632A1 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer
06/05/2002EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP1210127A1 Radiopharmaceutical products and their preparation procedure
06/05/2002EP1210125A2 L-selectin contrast agents
06/05/2002EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
06/05/2002EP1210068A2 Use of simple amino acids to form porous particles
06/05/2002EP0815134B1 Modulators of amyloid aggregation
06/04/2002US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation
06/04/2002US6399068 Cancer treatment, interleukins, fusion proteins, cell markers
06/04/2002US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection
06/04/2002US6399043 Radiolabeled macrocyclic gadolinium complexes with substantially better neural compatibility; enhanced signal intensity for nuclear spin tomography; water solubility and low osmolality; stable; nmr; radioimaging
06/04/2002US6399042 4-fluoroalkyl-3-halophenyl nortropanes
05/2002
05/30/2002WO2002041989A1 Metal-chelating adsorbents and their use
05/30/2002WO2002041923A1 Preparation for curing oncological disease, method for producing and using said composition
05/30/2002WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
05/30/2002WO2001083520A3 Polyacid glycopeptide derivatives
05/30/2002WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells
05/30/2002WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
05/30/2002US20020065429 Radioiodinated phospholipid ether analogs and methods of using the same
05/30/2002US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020064554 Radiation sensitive liposomes
05/30/2002US20020064500 Administering detectable amount of a radiolabeled compound of a class of benzisoxazoles; imaging brain to generate a brain image showing a distribution and relative amounts of acetylcholinesterase in brain
05/29/2002EP1208852A1 Neuropeptide Y1 receptor binding compounds in the treatment and diagnosis of cancer
05/29/2002EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications
05/29/2002EP1208116A2 Somatostatin analogs, radiolabelled derivatives thereof and their use
05/29/2002EP1207911A2 Improved container composition for radiopharmaceutical agents
05/29/2002EP1207910A2 Improved container composition for diagnostic agents
05/29/2002EP1207906A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies
05/29/2002EP1207904A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
05/28/2002US6395783 Treatment of PCP addiction and PCP addiction-related behavior
05/28/2002US6395255 Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
05/28/2002US6395254 Diagnosis of tumors and inflammatory disease
05/28/2002US6394945 Radioactively coated devices
05/28/2002CA2079493C Imaging agent for diagnosis
05/23/2002WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers
05/23/2002WO2002040092A2 Directional energy emitting implant
05/23/2002WO2002040060A2 Conjugates of an antioxidants with metal chelating ligands
05/23/2002WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
05/23/2002WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions
05/23/2002US20020061909 Vitronectin receptor antagonist pharmaceuticals
05/23/2002US20020061279 18F-labeled choline analogs
05/23/2002CA2421182A1 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
05/22/2002EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
05/22/2002EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives
05/22/2002EP1206288A2 Targeted fiberless radiative effectors
05/22/2002EP1206285A2 Drug-carrier complexes and methods of use thereof
05/22/2002EP1206252A1 Amplification of folate-mediated targeting to tumor cells using polymers
05/22/2002EP0745085B1 Texaphyrin metal complexes having improved functionalization
05/21/2002USRE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone
05/21/2002US6392246 Integrated radiation shield
05/21/2002US6391630 Nucleotide sequences for use in the diagnosis, prevention and treatment of cancer
05/21/2002US6391280 J chain polypeptide targeting molecule linked to an imaging agent
05/21/2002US6391279 Radioactive seeds for brachytherapy and a process for making the same
05/21/2002CA2148595C Molecule labelling using 2-hydrazinopyridine derivatives
05/16/2002WO2002022000A3 Targeted alpha particle therapy using actinium-225 conjugates
05/16/2002WO2001058434A3 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
05/16/2002US20020058853 Method of administering a therapeutically active substance
05/16/2002US20020058850 Radioactive medical devices and methods of making radioactive medical devices
05/16/2002US20020058615 Endothelial specific targeting
05/16/2002US20020058057 Brachytherapy seed
05/16/2002US20020058033 Human anti-epidermal growth factor receptor single-chain antibodies
05/16/2002US20020058007 Targeted alpha particle therapy using actinium-225 conjugates
05/15/2002EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
05/15/2002EP1204650A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents
05/15/2002EP1204426A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
05/14/2002US6387350 Utilizing a labeled single chain antibody fragment or subfragment with a molecular weight of 85,000 daltons or less that specifically binds to an antigen produced by or associated with tumors or lesions
05/14/2002CA2032499C Polypeptide derivatives
05/10/2002WO2002036771A2 Imaging, diagnosis and treatment of disease
05/10/2002WO2002036581A1 Radiopharmaceuticals for diagnosing alzheimer's disease
05/10/2002WO2002036174A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof
05/10/2002WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
05/10/2002WO2001077145A3 Integrin binding peptide derivatives
05/10/2002WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
05/10/2002WO2001019799A3 Nitroimidazole derivative and diagnostic imaging agent containing the same
05/10/2002CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
05/10/2002CA2427130A1 Radio-labelled ferrite particles and methods for the manufacture and use thereof
05/10/2002CA2424598A1 Radiopharmaceuticals for diagnosing alzheimer's disease